Understanding the Roundup Settlement: Key Facts and Figures

The Roundup litigation has become one of the most significant mass tort cases in recent history, with thousands of plaintiffs alleging that exposure to the glyphosate-based herbicide caused them to develop non-Hodgkin’s lymphoma and other cancers. As of April 2025, Bayer, which acquired Monsanto in 2018, has paid nearly $11 billion to resolve approximately 100,000 lawsuits.

Average Settlement Amounts

Individual settlement payouts have varied widely based on factors such as the severity of the illness, duration of Roundup exposure, and strength of evidence presented. Legal experts estimate that average settlements range from $5,000 to $250,000, with many plaintiffs receiving around $150,000 to $160,000.

Notable Verdicts

While many cases have settled out of court, several have proceeded to trial, resulting in substantial jury awards:

1. In January 2024, a Philadelphia jury awarded $2.25 billion to a plaintiff, later reduced to $400 million on appeal.

2. In March 2025, a Georgia jury ordered Bayer to pay $2.1 billion to a plaintiff who developed non-Hodgkin’s lymphoma after using Roundup.

3. In October 2024, a Pennsylvania man was awarded $78 million, including $75 million in punitive damages.

Bayer's Response and Ongoing Litigation

Bayer continues to assert that Roundup is safe when used as directed, citing regulatory approvals and scientific studies. However, the company has faced significant legal challenges, with over 60,000 cases still pending. Bayer has set aside an additional $5.9 billion to address future claims.

Conclusion

The Roundup litigation underscores the complexities of product liability cases, especially when scientific opinions diverge. As legal proceedings continue, the outcomes will likely influence corporate accountability and consumer safety standards in the agricultural industry.